A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis

SR Poort, FR Rosendaal, PH Reitsma, +1

Blood

Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families

BP Koeleman, PH Reitsma, C.F. Allaart, +1

Blood

Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor

Tadashi Matsushita, PH Reitsma, EA Tuley, +3

Blood

The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects

PH Reitsma, SR Poort, C.F. Allaart, +2

Blood

The putative factor IX gene promoter in hemophilia B Leyden

PH Reitsma, R M Bertina, JK Ploos van Amstel, +2

Blood

Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)

PH Reitsma, T Mandalaki, CK Kasper, +2

Blood

Hemophilia B Leyden: substitution of thymine for guanine at position - 21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter

M J Reijnen, Kathelijne Peerlinck, D Maasdam, +2

Blood

Altered bone morphogenetic protein signalling in the <i>Helicobacter pylori</i>‐infected stomach

SA Bleuming, María Jesús García-León, D. J. Richel, +2

The Journal of Pathology

Eleven novel mutations in the factor VIII gene from Brazilian hemophilia A patients

VR Arruda, W C Pieneman, PH Reitsma, +4

Blood